GreenLight XPS for treating benign prostatic hyperplasia (MTG74)Product type:GuidanceProgramme:Medical technologies guidancePublished: 29 November 2022
Optilume for treating recurrent bulbar urethral strictures (MTG73)Product type:GuidanceProgramme:Medical technologies guidancePublished: 29 November 2022
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG58)Product type:GuidanceProgramme:Medical technologies guidancePublished: 4 May 2021
The PLASMA system for transurethral resection and haemostasis of the prostate (MTG53)Product type:GuidanceProgramme:Medical technologies guidancePublished: 6 January 2021
Axonics sacral neuromodulation system for treating refractory overactive bladder (MTG50)Product type:GuidanceProgramme:Medical technologies guidancePublished: 3 September 2020
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (MTG49)Product type:GuidanceProgramme:Medical technologies guidancePublished: 24 June 2020
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasiaStatus:Awaiting developmentProgramme:Medical technologies guidanceExpected publication date: TBC
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisationStatus:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
PLASMA system for electrovaporisation of the prostate (MT597) (MIB274)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC